Cardinal Health Outlines Leadership Succession Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Cardinal Health (CAH) PT Lowered to $67 at Jefferies; Remains Sidelined
November 7, 2017 8:10 AM ESTJefferies lowered its price target on Cardinal Health (NYSE: CAH) to $67.00 (from $77.00) while maintaining a Hold rating following the company's earnings release. Despite missing consensus revenue by ~2.5% ($32.6B vs. $33.4B), CAH beat on earnings for the quarter as a result of better than expected... More
